Protagenic Therapeutics (STU:MBP) Accumulated other comprehensive income (loss) : €-0.12 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Protagenic Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Protagenic Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was €-0.12 Mil.

Protagenic Therapeutics's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (€-0.12 Mil) to Dec. 2024 (€-0.12 Mil) but then increased from Dec. 2024 (€-0.12 Mil) to Mar. 2025 (€-0.12 Mil).

Protagenic Therapeutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (€-0.64 Mil) to Dec. 2023 (€-0.11 Mil) but then declined from Dec. 2023 (€-0.11 Mil) to Dec. 2024 (€-0.12 Mil).

Protagenic Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Protagenic Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protagenic Therapeutics Accumulated other comprehensive income (loss) Chart

Protagenic Therapeutics Annual Data

Trend

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-0.14

-0.22

-0.64

-0.11

-0.12

Protagenic Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-0.08	-0.12	-0.12	-0.12	-0.12

Protagenic Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Protagenic Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Protagenic Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Protagenic Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protagenic Therapeutics Inc (STU:MBP) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

PTIX:USA

Address

149 Fifth Avenue, Suite 500, New York, NY, USA, 10010

Website

https://www.protagenic.com

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Protagenic Therapeutics Headlines

No Headlines